Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

New residences open on Bloemfontein Campus
2013-01-21

 

Photo: Johan Roux
21 January 2013



Beginning 2013, the Bloemfontein Campus is seeing the opening of two new residences where male and female students will be housed under one roof but in separate units. Each residence will house 250 students.

House ConLaurês and House Outeniqua were opened for their first-years and Residence Committee (RC) on Friday 18 January 2013. The two newly Residence Heads, Mr Frank Makhabane (ConLaurês) and Mrs Leani Wimble (Outeniqua) welcomed the new residents.

The uniqueness of these residences is that they will be the first co-ed residences on campus. These residences are wheel chair friendly with fully equipped disabled rooms available. All signage has also been done in Braille. Each floor of the new residences has two lounges, as well as a fully fitted kitchen.

The Prime of House ConLaurês, Sherilyn Roelofse, says, “We aim to create a living space that is holistic and welcoming and will allow our residence members to be able to excel in a number of things”. Sherilyn says ConLaurês comes from the word “Condo Laurus”, which means dreams of victory. The House’s slogan is “The Symphony of Dreams”. Students came up with the name for the residence.

Tsatsi Mokoena, RC member responsible for RAG at House ConLaurês says RC members have been working hard for the past few months, trying to imagine how to do things without a physical structure. ConLaurês will be a residence with an inspirational living space where each student feels welcome, respected for who they are and at home, so that they will have the confidence to follow their dreams.”

The Prime of Outeniqua, Vusumzi Mesatywa says, “Change is always welcome and that is the mindset that we will be embracing as the new residences. When a student graduates, we need them to graduate not only as academics, but also as humans, holistic beings”.

Marla Stanier, RC First-Year Mentor at Outeniqua, says that new experiences await every student that walks through the doors of the residence. “As excited as we are, this new experience will test us in many ways.However, if we stand together as one, we will succeed.”

Mr Quintin Koetaan, Director of Housing and Residence Affairs, says, “The opening of ConLaurês and Outeniqua is a dream come true, providing accommodation for a new generation of students in the 21st Century”.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept